Patheon’s Post

Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: 1️⃣ The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services 2️⃣ How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development 3️⃣ Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University, as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific, this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6048Slm9Y

Don't forget to sign up to our webinar to learn how integrating CDMO and CRO services can significantly boost your program's expected Net Present Value

Join our webinar to learn the benefits of combining CRO and CDMO services through ThermoFisher's Accelerator™ Drug Development

Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: • The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services • How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development • Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University, as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific, this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6044qxNiM

Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: • The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services • How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development • Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University, as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific, this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6046qxNbm

Checkout our most recent article by Mary Katherine DeVane, that explores the pivotal role of clinical research in speeding up drug development, highlighting key lessons learned during the pandemic and the lasting changes to clinical trials. Read more: https://ow.ly/s6cE50UlEYO #clinicaltrials #biotech #pharma #prestigescientific

No other organization can tackle the issues with supply chains, manufacturing, cross functional integration and clinical delivery better than Thermo Fisher Scientific. If speed to market in clinical research is key....take a look at our unique and integrated approach to drug development.

With #healthcaredemand surging due to an aging population and other critical factors, the need to accelerate innovation in #drugdevelopment has never been greater. Thermo Fisher Scientific’s new Accelerator™ Drug Development approach combines #CDMO and #CRO solutions in one streamlined service to bring treatments to patients faster. Learn more about this end-to-end offering for #biotech and #pharma #drugdevelopers in our blog, “Redefining acceleration of the #drugdevelopment journey”: http://spr.ly/6044sALLp

✨NEW BLOG ― Navigating the Complexities of First-in-Human Studies Our latest blog post is your go-to guide for understanding the critical role First-in-human or FIH studies play in drug development. From the inherent challenges and risks to strategic planning for success, we cover it all. Learn from past trials and discover key considerations for conducting your own FIH study with BioPharma Services. Don't miss out on these valuable insights! Learn more here 👇 https://hubs.li/Q02pNcNH0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #genericdrugs #biotech #pharmaceuticalindustry

CALLING ALL PHARMA AND BIOTECH MARKET ACCESS PROFESSIONALS! Your insights will help us understand if the European market access evidence requirements are being considered early enough when planning clinical development trials We invite you to complete this short survey (~ 2 minutes). All survey responses will remain anonymous. Link: https://lnkd.in/e5FJZiGE #marketaccess #pharma #biotech